SEC Form 4 · accession 0001144204-16-106875
ASSEMBLY BIOSCIENCES, INC. · ASMB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard D DiMarchi
Director
Period of report
Jun 2, 2016
Accepted (ET)
Jun 3, 2016 · 7:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001426800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 319,240 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to BuyF2 | $5.84 | Jun 2, 2016 | A | 10,000 | A | — | Jun 2, 2026 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1Includes 8,414 shares of Common Stock acquired by the reporting person pursuant to a pro rata liquidating distribution from Twilight Venture Partners II, LLC on May 4, 2015.
- F2The shares of Common Stock underlying the option will vest upon the earlier of (i) June 2, 2017 and (ii) the date of the Issuer's 2017 annual meeting of stockholders.